Belite Bio appoints Hendrik Scholl as CMO, bringing 20+ years of healthcare experience.
Belite Bio has appointed Hendrik Scholl as its new Chief Medical Officer. Scholl brings over 20 years of healthcare experience, particularly in drug development and regulatory affairs, having previously held significant roles at AstraZeneca. His expertise is expected to enhance Belite Bio's research and development initiatives.
September 01, 2024
4 Articles